NSE
BSEIn the news
Sugar Stocks: Valuation, Earnings, and the Debt Divide
Godavari Biorefineries posts ₹193 cr net loss in Q1 FY27
India's E85 ethanol rollout expands to 500 stations by end-2026
Godavari Biorefineries shares rally 6.95% on Japan cancer patent
Company insights, generated from the most recent coverage.
Stock declined 8.28% in August as widening EBITDA losses in sugar segment and stagnant ethanol prices created unfavorable sugar-ethanol economics, insulating it from sector rally.
The Quarter story
The two most recent quarterly results, compared side-by-side.
Godavari Biorefineries maintains stable top-line growth and cleaner operations, but faces seasonal profit swings and ethanol margin pressure.
Sugar & Cogeneration revenue grew from ₹177.5 Cr to ₹191.7 Cr from Q1 to Q4 FY26, showing steady demand.
Ethanol EBITDA fell from ₹13.1 Cr to ₹4.2 Cr from Q1 to Q3 FY26, signaling sustained margin compression.
Bio-Based Chemicals non-specialty mix expanded from 37% to 42% from Q2 to Q4 FY26, indicating successful volume growth.
Consolidated EBITDA margin swung from 1.2% to 0.5% from Q1 FY26 to Q1 FY27, reflecting seasonal pricing pressures.
Consolidated total income held steady from ₹534.0 Cr to ₹559.9 Cr from Q1 FY26 to Q1 FY27, reflecting stable top-line performance.
Consolidated PAT dropped from ₹-16.0 Cr to ₹-19.3 Cr from Q1 FY26 to Q1 FY27, highlighting seasonal earnings volatility.
Consolidated exceptional expenses dropped from ₹26.7 Cr to ₹0.0 Cr from Q2 FY26 to Q1 FY27, signaling cleaner operations.
Consolidated cost of materials shifted from ₹205.5 Cr to ₹185.5 Cr from Q1 FY26 to Q1 FY27, reflecting seasonal input pricing swings.
Consolidated depreciation rose from ₹13.5 Cr to ₹14.5 Cr from Q1 FY26 to Q1 FY27, confirming ongoing capacity expansion.
Consolidated inventory changes moved from ₹217.7 Cr to ₹263.2 Cr from Q1 FY26 to Q1 FY27, signaling active restocking cycles.